Skip to main content

Table 3 Prevalence of antimicrobial resistance in healthcare-onset/associated E. coli bacteriuria episodes compared to those that are community-onset, 2014–2020

From: Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare system

  RR (95% CI)
NIT T/S CIP ESBL Any AMR MDR
Community onset (reference)       
Healthcare onset/associated 1.98 (1.40, 2.79) 1.23 (1.14, 1.32) 1.96 (1.80, 2.13) 3.00 (2.65, 3.39) 1.17 (1.13, 1.22) 1.86 (1.69, 2.05)
  1. Data from a public healthcare system including inpatient and outpatient services and a skilled nursing facility; RR: risk ratio, NIT: nitrofurantoin, T/S: trimethoprim/sulfamethoxazole, CIP: ciprofloxacin, ESBL: extended-spectrum beta-lactamase, AMR: antimicrobial resistance, MDR: multidrug resistance